MedTrace Logo

Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination

NCT04909814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-06-07

No results posted yet for this study

Summary

Women were invited to attend colposcopy within two-four months after a positive screening test (two consecutive screening tests indicating low-grade squamous intraepithelial lesions (LSIL) and HPV positivity or a single screening test indicating high grade squamous intraepithelial lesions (HSIL)), according to national guidelines

Conditions

Interventions

BIOLOGICAL

The performance of colposcopy in vaccinated women

Evaluating the performance of colpscopy in HPV vaccinated women by comparing vaccinated and unvaccinated women taking their first test within the organized screening program

Sponsors & Collaborators

  • Falu Hospital

    lead OTHER

Principal Investigators

  • Hanna I Sahlgren, md · RCC

  • Miriam K Elfström, phd · RCC

Eligibility

Min Age
22 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-14
Primary Completion
2019-10-15
Completion
2019-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04909814 on ClinicalTrials.gov